leisure time -WSS

leisure time

author：hotspot 2025-10-01 20:14:28 - browse：58742

Duchenne muscular dystrophy is a devastating disease and, until very recently, was one without much hope. When Hawken Miller was diagnosed at age 5, the physician told his parents to enjoy the time they had with him, as there wouldn’t be much. Over 20 years later, Miller is a journalist and content strategist for CureDuchenne, an organization started by his mother when he was diagnosed, and new treatment is on the horizon.

Last month, the FDA approved a new gene therapy from Sarepta Therapeutics that will provide hope for many patients and families. The new drug, however, has its limitations — it’s only approved for children age 4-5, for example. Miller joined the podcast to discuss how this drug may change lives, what more needs to happen, and what his personal experience has been living with Duchenne.

“For the older boys, we’re running up against the clock a little bit with what we’re able to do and what we’re not able to do,” Miller said. “And if we’re able to try anything that could possibly help, I think most people would like the opportunity to do that.”

The conversation is based off his recent First Opinion, “The FDA’s approval of a new gene therapy for Duchenne muscular dystrophy won’t help me — but it gives me hope.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Feng Zhang CRISPR delivery startup lays off quarter of staff

WSS

The problems with dementia villages

3 trends to watch in health tech's hiring outlook for 2024

Roivant's CEO is a star, but biotech's black hole persists

GSK Flovent asthma inhalers replaced by authorized generics

UCB departs biotech trade group BIO

U.K. sequencing study surfaces new findings about tumor DNA

hotspot

leisure time

hotspot

At least 13 dead in Texas as scorching temps continue

Is there really a nursing shortage in the U.S.?

Walensky prepares to leave CDC — and Congress — behind

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Medical leaders decry Supreme Court decision on affirmative action

The FDA must approve intranasal treatments for anaphylaxis

State Dept. review finds Biden bears some blame for Afghanistan failures

STAT Readout Newsletter: Biotech news today

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

STAT Summit: Meghan O’Rourke on making chronic illness visible

entertainment

How a scoliosis diagnosis changed the life of one young dancer

How a scoliosis diagnosis changed the life of one young dancer

Is there really a nursing shortage in the U.S.?

Why a market frenzy over new weight loss drugs defies logic

Antibiotic resistance and the global rise in human conflict

3 medical device trends to watch in 2024

focus

Wikipedia

hotspot

hotspot